| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |